Arterial spin labeled perfusion MRI for the assessment of radiation-treated meningiomas

Paul Manning1,2, Shanmukha Srinivas2, Divya S Bolar1,3

  • 1Department of Radiology, University of California, San Diego, San Diego, CA, United States.

PubMed
Abstract

Insights

3D pseudocontinuous arterial spin labeling (3D pCASL) MRI shows decreased cerebral blood flow in radiation-treated meningiomas, offering complementary insights beyond conventional MRI. This perfusion imaging may aid clinical decisions and serve as a trial endpoint.

Area of Science:

  • Neuroimaging
  • Radiology
  • Oncology

Background:

  • Conventional contrast-enhanced MRI is the standard for evaluating radiation treatment response in meningiomas.
  • Perfusion-weighted MRI techniques, like 3D pseudocontinuous arterial spin labeling (3D pCASL), offer physiological data beyond structural information.
  • 3D pCASL may provide complementary information for assessing treatment response in meningiomas.

Purpose of the Study:

  • To assess the utility of 3D pCASL MRI in evaluating radiation-treated meningiomas.
  • To compare the effectiveness of 3D pCASL with conventional contrast-enhanced MRI for treatment response assessment.

Main Methods:

  • Retrospective study of 20 patients with meningiomas treated with surgery and/or radiation.
  • Patients underwent 3D pCASL and contrast-enhanced MRI before and after radiation therapy.
  • Measurements included ASL-normalized cerebral blood flow (ASL-nCBF) and contrast-enhancing area; Wilcoxon signed-rank tests were used for comparison.

Main Results:

  • All treated meningiomas showed a significant decrease in ASL-nCBF post-radiation (p < 0.001).
  • Contrast-enhancing area decreased in only half of the meningiomas, remaining stable in the other half.
  • ASL-nCBF measurements demonstrated a larger effect size (r=0.877) compared to contrast-enhanced area measurements (r=0.597).

Conclusions:

  • 3D pCASL perfusion imaging provides complementary information for evaluating radiation response in meningiomas.
  • This technique may enhance clinical decision-making for meningioma patients.
  • 3D pCASL could serve as an additional endpoint in clinical trials for radiation-treated meningiomas.